Results 111 to 120 of about 9,281 (210)

Response to treatment in NMOSD: the Australasian experience

open access: yes, 2021
Background: Neuromyelitis optica spectrum disorder (NMOSD) is associated with significant morbidity and mortality. Several therapies have been recommended for NMOSD and more recently clinical trials have demonstrated efficacy for three monoclonal ...
Clarke, L.   +26 more
core  

Inflammatory and Nutritional Markers as Indicators for Diagnosing and Assessing Disease Activity in MS and NMOSD

open access: yesJournal of Inflammation Research
Xiaotong Li,1– 3,* Wencan Jiang,1– 3,* Guoge Li,1– 3 Yaowei Ding,1– 3 Haoran Li,1– 3 Jialu Sun,1– 3 Yuxin Chen,1– 3 Siqi Wang,1– 3 Guojun Zhang1– 3 1Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital, Capital Medical ...
Li X   +8 more
doaj  

Apheresis therapies for NMOSD attacks

open access: yes, 2018
\(\bf Objective\) To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica spectrum disorder (NMOSD) attacks and to identify predictive factors for complete remission (CR).
Kleiter, Ingo Wolfram (Prof. Dr. med.)   +38 more
openaire   +1 more source

Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack. [PDF]

open access: yesEur J Neurol
Rival M   +40 more
europepmc   +1 more source

MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation:a systematic review and meta-analysis

open access: yes
Background Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can share similar features, posing diagnostic challenges.
Adamou, Antonis   +14 more
core   +1 more source

NMOSD and MOGAD Dual Positivity

open access: yesAnnals of Indian Academy of Neurology, 2022
Ayush Agarwal   +5 more
openaire   +3 more sources

Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Wingerchuk DM   +14 more
europepmc   +1 more source

Plasmapheresis for NMOSD: Not a rescue therapy anymore!?

open access: yesAnnals of Indian Academy of Neurology, 2019
Rohit Bhatia   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy